EQT acquires minority stake in SHL Medical

The EQT VIII Fund (“EQT”) announced that it has entered into an agreement to acquire a minority stake in SHL Medical (“SHL”). Headquartered in Switzerland, SHL is a world-leading provider of drug delivery solutions such as autoinjectors and serves as a partner to global pharmaceutical companies and biotech firms. The transaction is subject to customary regulatory approvals.

Niederer Kraft Frey acts as Swiss legal advisor to EQT in this transaction. The team is led by partner Till Spillmann (M&A, Finance), working with partner Clara-Ann Gordon (Technology, Data Protection), senior associates Adrian Koller (M&A, Finance) and Michaela Zehnder (IP), associate Katalin Siklosi (M&A) and junior associates Tanja Lutz and Patrick Janshekar (both M&A).